多参数前列腺MRI与18F-胆碱PET/CT在局灶性前列腺癌治疗应用中的肿瘤分割准确性
研究评估多参数前列腺MRI(mpMRI)与18F-胆碱PET/CT在临床显著前列腺癌肿瘤分割中的准确性。10例前瞻性受试者在前列腺切除术前接受18F-胆碱PET/CT和3T mpMRI,所有受试者均有单个活检证实的Gleason≥3+4癌灶。两种影像分割方法均大幅低估真实肿瘤体积,结合代谢信息可改善肿瘤覆盖,但需进一步临床研究确认。
要点
- 所有分割方法均大幅低估真实肿瘤体积,人读者和PET分割平均低估分别为79%、80%和58%。
- 联合三种分割并外扩5mm轮廓可将平均低估肿瘤体积显著降至0.03±0.05mL(2.04±2.84%)。
- 结合18F-胆碱代谢信息与MRI分割可将覆盖全部肿瘤所需安全边距最大降至9mm。
核心结论
- 为改善临床显著前列腺癌局灶治疗的结局,必须认识到mpMRI对肿瘤体积的低估程度。
- 将18F-胆碱的代谢信息与基于MRI的分割相结合可改善肿瘤覆盖,但该方法需在进一步临床研究中确认。
研究设计与样本
- 前瞻性研究纳入10例受试者,前列腺切除术前接受18F-胆碱PET/CT和3T mpMRI,均有单个活检证实的Gleason≥3+4癌灶。
- 两名放射科医生基于体内mpMRI序列确定肿瘤边界,并结合临床和病理数据。
- 18F-胆碱PET数据与T2加权3D序列配准,采用半自动分割常规定义肿瘤体积。
- 利用两例离体前列腺标本MRI将全mount外科病理与体内影像配准,随后在定制3D打印塑料模具内对标本进行大体切片。
- 比较手动分割(seg1、seg2)和基于18F-胆碱的分割病灶(seg3)与病理参考标准的重叠和相似系数。
主要发现
- 所有分割方法均大幅低估真实肿瘤体积,人读者(seg1、seg2)和PET分割(seg3)分别平均低估肿瘤体积的79%、80%和58%。
- 联合分割体积(seg1、seg2、seg3的并集=seg4)将平均低估肿瘤体积降至真实肿瘤体积的42%。
- 使用联合分割并外扩5mm轮廓时,平均低估肿瘤体积显著降至0.03±0.05mL(2.04±2.84%)。
- 当初始分割边界由人读者或半自动18F-胆碱分割工具勾画时,需高达11-15mm的较大安全边距才能覆盖全部肿瘤。
- 将基于MRI的人工分割与基于18F-胆碱PET的代谢信息相结合,将覆盖全部肿瘤所需安全边距最大降至9mm。
关键数值与推荐
- 人读者seg1平均低估肿瘤体积79%,seg2平均低估80%,PET分割seg3平均低估58%。
- 联合分割seg4将平均低估肿瘤体积降至42%。
- 联合分割加5mm轮廓外扩后平均低估肿瘤体积为0.03±0.05mL(2.04±2.84%)。
- 人读者或半自动18F-胆碱分割需高达11-15mm安全边距以覆盖全部肿瘤。
- 结合MRI人工分割与18F-胆碱PET代谢信息后,所需安全边距最大为9mm。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论指出该方法需在进一步临床研究中确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The study aims to assess the accuracy of multi-parametric prostate MRI (mpMRI) and 18F-choline PET/CT in tumor segmentation for clinically significant prostate cancer. 18F-choline PET/CT and 3 T mpMRI were performed in 10 prospective subjects prior to prostatectomy. All subjects had a single biopsy-confirmed focus of Gleason ≥ 3+4 cancer. Two radiologists (readers 1 and 2) determined tumor boundaries based on in vivo mpMRI sequences, with clinical and pathologic data available. 18F-choline PET data were co-registered to T2-weighted 3D sequences and a semi-automatic segmentation routine was used to define tumor volumes. Registration of whole-mount surgical pathology to in vivo imaging was conducted utilizing two ex vivo prostate specimen MRIs, followed by gross sectioning of the specimens within a custom-made 3D-printed plastic mold. Overlap and similarity coefficients of manual segmentations (seg1, seg2) and 18F-choline-based segmented lesions (seg3) were compared to the pathologic reference standard. RESULTS: All segmentation methods greatly underestimated the true tumor volumes. Human readers (seg1, seg2) and the PET-based segmentation (seg3) underestimated an average of 79, 80, and 58% of the tumor volumes, respectively. Combining segmentation volumes (union of seg1, seg2, seg3 = seg4) decreased the mean underestimated tumor volume to 42% of the true tumor volume. When using the combined segmentation with 5 mm contour expansion, the mean underestimated tumor volume was significantly reduced to 0.03 ± 0.05 mL (2.04 ± 2.84%). Substantial safety margins up to 11-15 mm were needed to include all tumors when the initial segmentation boundaries were drawn by human readers or the semi-automated 18F-choline segmentation tool. Combining MR-based human segmentations with the metabolic information based on 18F-choline PET reduced the necessary safety margin to a maximum of 9 mm to cover all tumors entirely. CONCLUSIONS: To improve the outcome of focal therapies for significant prostate cancer, it is imperative to recognize the full extent of the underestimation of tumor volumes by mpMRI. Combining metabolic information from 18F-choline with MRI-based segmentation can improve tumor coverage. However, this approach requires confirmation in further clinical studies.
引用
- Piert M, Shankar PR, Montgomery J, et al. Accuracy of tumor segmentation from multi-parametric prostate MRI and 18F-choline PET/CT for focal prostate cancer therapy applications. EJNMMI Res. 2018. PMID: 29589155. doi:10.1186/s13550-018-0377-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。